Zonnic Mint Lozenges (4 mg nicotine lozenges)
Natural health product licensed in Canada
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Pyridine, 3-(1-méthyl-2-pyrrolidinyl)-, (S)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:2) Source : Tartrate de nicotine Potency : 4 milligramme Nicotine | 12.29 milligramme |
Non-medicinal ingredients
Eau purifiée, Carbonate de sodium anhydre, Saveur de menthe, Solution de maltitol, Isomalt, Acésulfame-K, Bleu 1
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Pastille | minimum: 8 Tous les jours ; maximum: 15 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
The nicotine in Zonnic Mint relieves craving for nicotine and withdrawal symptoms when you stop smoking and counteracts thereby relapse into smoking in smokers who are motivated to stop; or acts as a temporary aid to those who want to stop smoking cigarettes or break the cigarette habit, when used as part of a smoking cessation program. By means of Zonnic Mint you can reduce the discomfort of withdrawal symptoms, by continuing to provide a small amount of nicotine to your body during a short period of time. The effectiveness of this product is directly related to your motivation to stop smoking. Consult your pharmacist or doctor regarding the availability of smoking cessation programs in your area.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Product record
- Licence holder
- Niconovum AB
- NPN or DIN-HM
- 80064786
- Status
- Active licence
- Licence date
- 26 October 2015
- Revision date
- 15 June 2023
- Form
- Pastille
- Route of administration
- Buccale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80064786
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Zonnic Mint Lozenges (4 mg nicotine lozenges)”, https://compoatlas.com/en/supplements/canada/80064786-zonnic-mint-lozenges-4-mg-nicotine-lozenges, updated 15 June 2023.